uridine diphosphate has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Chen, Z; Huang, B; Huang, J; Li, L; Liu, X; Wu, B; Wu, D; Zhan, H; Zhang, S | 1 |
1 other study(ies) available for uridine diphosphate and Hyperplasia
| Article | Year |
|---|---|
Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia.
Topics: Androgens; Animals; Apoptosis; Dihydrotestosterone; Glucuronosyltransferase; Humans; Hyperplasia; Male; Naphthalenes; Piperazines; Prostate; Prostatic Hyperplasia; Rats; Receptors, Androgen; Uridine Diphosphate | 2022 |